Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8704350rdf:typepubmed:Citationlld:pubmed
pubmed-article:8704350lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8704350lifeskim:mentionsumls-concept:C0029936lld:lifeskim
pubmed-article:8704350lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:8704350lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8704350lifeskim:mentionsumls-concept:C0145942lld:lifeskim
pubmed-article:8704350lifeskim:mentionsumls-concept:C0042382lld:lifeskim
pubmed-article:8704350lifeskim:mentionsumls-concept:C0085268lld:lifeskim
pubmed-article:8704350lifeskim:mentionsumls-concept:C0595613lld:lifeskim
pubmed-article:8704350pubmed:issue2lld:pubmed
pubmed-article:8704350pubmed:dateCreated1996-9-12lld:pubmed
pubmed-article:8704350pubmed:abstractTextIn order to study the action of tiludronate on the changes in intraosseous vascularization induced by ovariectomy, and to link these effects to those observed in bone remodelling, 30 female Sprague-Dawley rats (age 40 weeks) were studied. Ten rats were shamoperated and treated by vehicle, 10 rats were ovariectomized and treated by vehicle, and 10 rats were ovariectomized and treated orally with tiludronate, 0.16 mmol/kg/per day, 3 days a week for 16 weeks, from the day following ovariectomy. The rats were killed after 4 months, and a histomorphometric study and quantification of intraosseous vessels carried out on the sixth lumbar vertebra. The area of the intraosseous sinusoidal capillaries increased after ovariectomy, which also induced a moderate increase in resorption surfaces and osteoid surfaces leading to a decrease of 40% in the trabecular bone volume at the lumbar spine level. This bone mineral loss was completely prevented by tiludronate, which normalized the bone turnover. However, tiludronate was without any effect on intraosseous vascularization. These results indicate that the surface area of the intraosseous sinusoidal capillaries was correlated positively with resorption surfaces and negatively with trabecular bone volume and the number of bone trabeculae. In these experimental conditions, an inhibitor of bone resorption can exert its positive effect on bone mass without normalization of vascularization.lld:pubmed
pubmed-article:8704350pubmed:languageenglld:pubmed
pubmed-article:8704350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8704350pubmed:citationSubsetIMlld:pubmed
pubmed-article:8704350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8704350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8704350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8704350pubmed:statusMEDLINElld:pubmed
pubmed-article:8704350pubmed:issn0937-941Xlld:pubmed
pubmed-article:8704350pubmed:authorpubmed-author:BarbierAAlld:pubmed
pubmed-article:8704350pubmed:authorpubmed-author:LarocheMMlld:pubmed
pubmed-article:8704350pubmed:authorpubmed-author:MazieresBBlld:pubmed
pubmed-article:8704350pubmed:authorpubmed-author:LudotIIlld:pubmed
pubmed-article:8704350pubmed:authorpubmed-author:ThiechartMMlld:pubmed
pubmed-article:8704350pubmed:authorpubmed-author:VernhetCClld:pubmed
pubmed-article:8704350pubmed:authorpubmed-author:ViguierGGlld:pubmed
pubmed-article:8704350pubmed:issnTypePrintlld:pubmed
pubmed-article:8704350pubmed:volume6lld:pubmed
pubmed-article:8704350pubmed:ownerNLMlld:pubmed
pubmed-article:8704350pubmed:authorsCompleteYlld:pubmed
pubmed-article:8704350pubmed:pagination127-9lld:pubmed
pubmed-article:8704350pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:meshHeadingpubmed-meshheading:8704350-...lld:pubmed
pubmed-article:8704350pubmed:year1996lld:pubmed
pubmed-article:8704350pubmed:articleTitleEffect of ovariectomy on intraosseous vascularization and bone remodelling in rats: action of tiludronate.lld:pubmed
pubmed-article:8704350pubmed:affiliationService de Rhumatologie, CHU Rangueil, Toulouse, France.lld:pubmed
pubmed-article:8704350pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8704350pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8704350lld:pubmed